Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa.
about
Fibrinolytic and coagulative activities of Yersinia pestisLethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injuryThe 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilization4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumoniaA biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study.Plasminogen activator inhibitor-type I gene deficient mice show reduced influx of neutrophils in ventilator-induced lung injuryCytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice.Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study.Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.Update on the treatment of Pseudomonas aeruginosa pneumonia.Genetic predisposition to respiratory infection and sepsis.Protein C and acute inflammation: a clinical and biological perspective.PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in miceEndogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis).
P2860
Q26862503-EFCD59BB-FE21-460C-A69B-9DF6C73213C6Q30407311-070CA371-9F66-4279-804C-1795A064696BQ33595107-4029952D-EAE8-42DC-AF07-407322523351Q33599073-FEF5E944-F7AD-4EC8-AC5C-FBDCDCF5E8B8Q33919345-F72CA9EA-4066-443A-8362-4317D9F4F0D7Q34022566-45CC8145-FB66-4829-9895-57C9FF4D51DAQ34302316-8FC39054-FF93-4BBD-A2F1-F6C261EF6FFEQ35119519-CF561EBA-0D1D-4108-A00E-EB5305F4DB3FQ35219875-1BFAA5B5-E597-47B3-9167-38220FE7FDA6Q35567004-45F0FD68-1EA4-465B-BD31-4C966F899E80Q36351797-0450999F-B3C8-483B-9A0F-56F24F490D68Q36889954-3C210E30-E188-48BA-AF21-724A55E4F50FQ37516904-2873A1B5-AC4E-4328-BBA3-C1568529C966Q37970138-24D3DC0B-7FC2-47E3-BD73-237E30383596Q38126264-D5C3F6C1-0363-49D7-BB70-BCAE84AE62A4Q41261629-CDE53A03-81B5-4BB4-97EC-6239B341EAD9Q55057343-2D1C86D8-847F-435E-A7C3-F7E8A08A563F
P2860
Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Increased plasminogen activato ...... s with Pseudomonas aeruginosa.
@en
Increased plasminogen activato ...... s with Pseudomonas aeruginosa.
@nl
type
label
Increased plasminogen activato ...... s with Pseudomonas aeruginosa.
@en
Increased plasminogen activato ...... s with Pseudomonas aeruginosa.
@nl
prefLabel
Increased plasminogen activato ...... s with Pseudomonas aeruginosa.
@en
Increased plasminogen activato ...... s with Pseudomonas aeruginosa.
@nl
P2093
P1433
P1476
Increased plasminogen activato ...... s with Pseudomonas aeruginosa.
@en
P2093
Amua Rubio-Mills
David Glidden
Gaurav Singh
Hanjing Zhuo
Jeanine P Wiener-Kronish
Judith Flanagan
Marshall S Baek
Oscar Garcia
Rachel H Dotson
P304
P356
10.1097/00000542-200702000-00012
P407
P50
P577
2007-02-01T00:00:00Z